Video

Dr Richard Snyder Emphasizes the Importance of Care Coordination in Value-Based Contracting

Population health management and coordination of care are integral to value-based contracting, explained Richard Snyder, MD, executive vice president of Facilitated Health Networks and chief medical officer at Independence Blue Cross.

Population health management and coordination of care are integral to value-based contracting, explained Richard Snyder, MD, executive vice president of Facilitated Health Networks and chief medical officer at Independence Blue Cross.

Transcript

How important are population health management and coordination of care in value-based contracting?

They’re actually integral to value-based contracting. When we do episode of care payments, we are paying for a period of time and everything that happens in that period of time, so it’s critically important that the right patients are chosen for that episode, that there’s extremely good coordination to prevent leakage out of the system of care to other systems, and ultimately that patients adhere to any medication regimens that they’re prescribed and that post-acute care when the patient goes home for a period of time, that’s included in the episode, is well managed so they don’t bounce back to an emergency room or a hospital or end up having a complication that could have been otherwise avoided if we had been monitoring them more closely.

In today’s world, we have technology, whether it’s video capabilities or Bluetooth enabled monitoring devices to determine whether patients are adhering to their treatment plans and whether they’re having any early signs of a complication that could result in a readmission to the hospital or emergency room or avoidable testing and treatment.

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo